Canary Capital has filed with the SEC to introduce a staked Injective exchange-traded fund (ETF). This fund will enable investors to track the price of Injective's native token, INJ, while also allowing them to stake the tokens and earn rewards. The staked ETF aims to provide a compliant and secure investment vehicle amidst growing interest in altcoin-focused financial products. The move reflects a wider trend in the cryptocurrency market, where asset managers are seeking to combine staking with ETF structures to attract more participants. Canary also established a Delaware Trust to support this initiative. This filing is part of a broader push by various asset managers, including renowned firms like 21Shares and Grayscale, to integrate staking features into their crypto funds. Injective, ranked 88th in market value, is currently trading at approximately $13.84. These developments illustrate the crypto sector's evolution toward offering yield-bearing instruments to meet investor demand.

Source 🔗